Co-Founder & CEO, Elucidata
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
Gen AI has the potential to transform the drug discovery field. However, these models need to be trained with quality datasets before they can be productionized. Using an inadequately trained model in this context can result in inaccurate predictions, unviable outcomes, and significant project expenses. In this session, Dr. Jha discusses the importance of data quality in training Gen AI models and its role in enhancing the robustness and reliability of target prediction in the pharmaceutical industry.
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
In this keynote session, Dr Ma'ayan delves into the transformative impact of generative AI and LLMs in the analysis of gene sets. He discusses how these innovations are enhancing gene annotation prediction, ultimately leading to the discovery of novel therapeutic targets across a broad spectrum of biomedical research applications.
Senior Adviser to the Milken Institute's FasterCures
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
Our keynote speaker, John Wilbanks is a distinguished authority in the field of data governance, backed by a wealth of experience and a forward-thinking vision regarding the future of data and AI. In his session, he sheds light on the hurdles and prospects of effectively implementing data governance strategies that unlock the potential of generative AI.
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
GenAI is as promising as it is challenging. To stay on top, scientists will have to combine data, infrastructure, models, and subject-matter expertise into a formidable base. While Gen AI is incredibly exciting, what does it really take to get these models into production? How can we keep trusting the results? How does one select the right problem? In this session, Swetabh gives us a breakdown of the tools needed to set your GenAI initiatives up for success.
Chetanya Pandya
Global Head of Data Engineering, Oncology, Sanofi
Ming Tommy Tang
Director of Computational Biology, Immunitas Therapeutics
Helena Deus
Principal, Technology Consulting, EPAM Systems
Prashant Natarajan
Vice President, Strategy and Products, H2O.ai
Jainik Dedhia
Senior Product Manager, Elucidata
Vladimir Makarov
Innovation Leader in Computational Biology
The panel elucidates on the rise of generative models in drug discovery.Topics covered:
Christopher Plescia
Director, Clinical Biomarker Technical Lead, Hookipa Pharma
Xitong Li
Chief Technology Officer,
NextGen Jane, Inc.
Neychelle Fernandes
Director of Solutions and Technical Sales, Elucidata
The fireside chat focuses on data management strategy in early stage R&D. Effective data management plays a pivotal role in the pharmaceutical industry. In this conversation, our panelists will cover: